Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet).

Francesco PanzutoM MaccauroD CampanaA FaggianoS MassironiS PuscedduF SpadaD FeroneR ModicaC M GranaP FerollaM RinzivilloG BadalamentiM C ZatelliF GelsominoE De CarloM BartolomeiM P BrizziS CingarliniA VersariG FanciulliE ArvatE MerolaM CivesS TafutoS BaldariM Falconi

Published in: Journal of endocrinological investigation (2020)

Although the COVID-19 outbreak induced the centers to reduce some important activities in the management of NEN patients, the Italian network was able to provide continuity in care without withdrawing anti-tumor treatment for the majority of patients.

Keyphrases

sars cov
end stage renal disease
ejection fraction
chronic kidney disease
healthcare
prognostic factors
neuroendocrine tumors
peritoneal dialysis
palliative care
patient reported outcomes
high grade
high glucose
pain management
replacement therapy